Oncolytics Biotech ONCY
NASDAQ ONCY
$0.51 +0.01 (+2.57%)
At close: Oct 21, 2026 · 4:00 PM EDT

Oncolytics Biotech (ONCY) Total Non-Current Liabilities (2009 - 2025)

Updated

Oncolytics Biotech's Total Non-Current Liabilities was $10.73 million in Q3 2025, down 2.7% from $11.03 million a year earlier but up 15.3% from the prior quarter.

Analysis

Oncolytics Biotech (ONCY) Total Non-Current Liabilities (2009 - 2025) Analysis & Trends

At the end of FY2024, Total Non-Current Liabilities at Oncolytics Biotech came in at $9.19 million, up 13.5% from FY2023.

  • Total Non-Current Liabilities shows a five-year compound annual growth rate of 12.1% (FY2019 to FY2024).
  • In earlier years, Total Non-Current Liabilities was $8.1 million in FY2023 (-2.8%), $8.33 million in FY2022 (+10.7%), $7.52 million in FY2021 (+46.4%) and $5.14 million in FY2020 (-1.1%).
  • Quarterly Total Non-Current Liabilities has moved between $4.59 million (Q1 2022) and $12.66 million (Q3 2023) over five years.
  • Compared with a year earlier, Total Non-Current Liabilities was higher in six of the last eight quarters, with growth averaging 6.5%.
  • The best year-over-year quarter for Total Non-Current Liabilities over five years was Q3 2023 (growth of 57.1%); the worst was Q1 2022 (a decline of 18.2%).
  • Per Business Quant data, ONCY's Total Non-Current Liabilities in the three quarters before Q3 2025 was $9.31 million (Q2 2025), $8.84 million (Q1 2025) and $9.01 million (Q4 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 60.66 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 105.50 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 106.45 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 80.25 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 48.34 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 33.91 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 78.66 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 35.10 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 97.04 Bn
10 Oncolytics Biotech 60.94 Mn 32.05 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 9.40 Mn
Mar 31, 2025 8.38 Mn
Dec 31, 2024 9.22 Mn
Sep 30, 2024 10.45 Mn
Jun 30, 2024 9.42 Mn
Mar 31, 2024 8.24 Mn
Dec 31, 2023 8.51 Mn
Sep 30, 2023 8.80 Mn
Jun 30, 2023 7.23 Mn
Mar 31, 2023 7.05 Mn
Dec 31, 2022 7.99 Mn
Sep 30, 2022 7.69 Mn
Jun 30, 2022 7.32 Mn
Mar 31, 2022 4.66 Mn
Dec 31, 2021 4.84 Mn
Sep 30, 2021 5.62 Mn
Jun 30, 2021 5.84 Mn
Mar 31, 2021 5.63 Mn
Dec 31, 2020 5.40 Mn
Sep 30, 2020 6.91 Mn
API Access

Oncolytics Biotech Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=ONCY&period=max&api_key=YOUR_API_KEY